AMGN vs BKYI · P/E 24, rev $10.05B vs rev $4.1M
Amgen Inc (AMGN) versus BIO-Key International Inc (BKYI) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
BIO-Key International Inc (BKYI) is a security & protection services company listed on NASDAQ.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported BKYI revenue for 2026-06-30 was $4.1M. Net income was -$781.9K. Revenue was up 89.5% from 2026-03-31 to 2026-06-30. BKYI currently screens at market cap $4.2M.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. BKYI currently screens at market cap $4.2M.
Not investment advice. Open the AMGN and BKYI stock pages for the full models.
Not investment advice.